Report 2019-105 Recommendation Responses
Report 2019-105: Childhood Lead Levels: Millions of Children in Medi-Cal Have Not Received Required Testing for Lead Poisoning (Release Date: January 2020)
Recommendation for Legislative Action
To support CDPH's efforts to efficiently monitor lead test results, the Legislature should amend state law to require that laboratories report Medi-Cal identification numbers or equivalent identification numbers with all lead test results.
Description of Legislative Action
AB 2326 (Chapter 528, Statutes of 2022) requires, in part, that, beginning on July 1, 2023, a laboratory that performs a blood lead analysis report to the California Department of Public Health (CDPH) the person's Medi-Cal client identification number (CIN) or, for other health plans, the name of the health plan and the medical plan identification number unless the health care provider cannot, or will not, provide the requested information.
- Legislative Action Current As-of: March 2023
California State Auditor's Assessment of Annual Follow-Up Status: Legislation Enacted
Description of Legislative Action
As of January 7, 2022, the Legislature has not taken action to address this specific recommendation.
- Legislative Action Current As-of: January 2022
California State Auditor's Assessment of Annual Follow-Up Status: No Action Taken
Description of Legislative Action
As of January 7, 2021, the Legislature has not taken action to address this specific recommendation.
AB 2278 (Quirk, 2020) would have required a laboratory that performs a blood lead analysis to report to CDPH, among other things, the Medi-Cal identification number and medical plan identification number, if available, for each analysis on every person tested. This bill failed passage due to adjournment of the 2019-20 Regular Legislative Session.
AB 2422 (Grayson, 2020) would have added the Medi-Cal identification number, or other equivalent medical identification number of the person tested to the information that a laboratory is required to provide regarding blood lead level tests. AB 2422 also would have required, if the person tested is a minor, the laboratory to include the person's contact information and a unique identifier, in a form to be determined by CDPH.
- Legislative Action Current As-of: January 2021
California State Auditor's Assessment of 1-Year Status: Legislation Proposed But Not Enacted
Description of Legislative Action
AB 2278 (Quirk) would require a laboratory that performs a blood lead analysis to report to CDPH, among other things, the Medi-Cal identification number and medical plan identification number, if available, for each analysis on every person tested. As of July 7, 2020, this bill was pending in the Assembly Health Committee.
AB 2422 would add the Medi-Cal identification number, or other equivalent medical identification number of the person tested to the information that a laboratory is required to provide regarding blood lead level tests. AB 2422would require, if the person tested is a minor, the laboratory to include the person's contact information and a unique identifier, in a form to be determined by CDPH.
- Legislative Action Current As-of: July 2020